Summary
Latest filing:
Tyler Zeronda is Director of Yarrow Bioscience, Inc. (YARW). 7 SEC Form 4 filings on record going back to 2024, most recently on 30 July 2026.
Recent Transactions
6Every recent SEC Form 4 transaction Tyler Zeronda has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Tyler Zeronda's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Herriot Tabuteau - $103.22M of AXSM open-market activity in the last 12 months
- Bruce Booth - $100.59M of KYMR open-market activity in the last 12 months
- ADAR1 Capital Management, LLC - $95.66M of KROS open-market activity in the last 12 months
- Paul A. Mahon - $94.95M of UTHR open-market activity in the last 12 months
- Steven Leonard Chapman - $93.07M of NTRA open-market activity in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M of MANE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Tyler Zeronda?
Tyler Zeronda is a corporate insider, tracked as Director of Yarrow Bioscience, Inc. (YARW). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Tyler Zeronda submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Tyler Zeronda's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Tyler Zeronda and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
